Orpea ACT (ORPEF, $1.92) was a top loser over the last three months, falling -2 to $1.92 per share. A.I.dvisor analyzed 106 stocks in the Medical/Nursing Services Industry for the 3-month period ending July 31, 2023, and found that of them (6) exhibited an Uptrend while of them (3) demonstrated a Downtrend. 458 similar cases when ORPEF's price dropped within three months. In out of those 458 cases, ORPEF's price went down during the following month. Based on these historical data, the odds of a Downtrend continuation for ORPEF are